USE OF HUMAN RECOMBINANT ERYTHROPOIETIN AND PREDNISONE FOR TREATMENT OF MYELODYSPLASTIC SYNDROME WITH ERYTHROID PREDOMINANCE IN A DOG

Authors
BOONE LI KNAUER KW RAPP SW STEWART JF MODIANO JF
Citation
Li. Boone et al., USE OF HUMAN RECOMBINANT ERYTHROPOIETIN AND PREDNISONE FOR TREATMENT OF MYELODYSPLASTIC SYNDROME WITH ERYTHROID PREDOMINANCE IN A DOG, Journal of the American Veterinary Medical Association, 213(7), 1998, pp. 999
Citations number
18
Categorie Soggetti
Veterinary Sciences
Journal title
Journal of the American Veterinary Medical Association → ACNP
ISSN journal
00031488
Volume
213
Issue
7
Year of publication
1998
Database
ISI
SICI code
0003-1488(1998)213:7<999:UOHREA>2.0.ZU;2-1
Abstract
The term ''myelodysplastic syndrome'' refers to any of a group of myel oproliferative disorders characterized by anemia, neutropenia, or thro mbocytopenia accompanied by dysplasia of the hematopoietic stem cells in bone marrow, with blast cells comprising less than 30% of the nucle ated cell population in bone marrow. Administration of erythropoietin may be useful in the management of refractory anemia associated with m yelodysplastic syndrome in dogs.